Signaling mechanisms in neuroendocrine tumors as targets for therapy.
about
Gastroenteropancreatic neuroendocrine tumors: new insights in the diagnosis and therapy.Signaling pathways as specific pharmacologic targets for neuroendocrine tumor therapy: RET, PI3K, MEK, growth factors, and Notch.Thiocoraline alters neuroendocrine phenotype and activates the Notch pathway in MTC-TT cell line.Targeted therapy of gastroenteropancreatic neuroendocrine tumours: preclinical strategies and future targets.Molecular challenges of neuroendocrine tumors.
P2860
Signaling mechanisms in neuroendocrine tumors as targets for therapy.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Signaling mechanisms in neuroendocrine tumors as targets for therapy.
@ast
Signaling mechanisms in neuroendocrine tumors as targets for therapy.
@en
Signaling mechanisms in neuroendocrine tumors as targets for therapy.
@nl
type
label
Signaling mechanisms in neuroendocrine tumors as targets for therapy.
@ast
Signaling mechanisms in neuroendocrine tumors as targets for therapy.
@en
Signaling mechanisms in neuroendocrine tumors as targets for therapy.
@nl
prefLabel
Signaling mechanisms in neuroendocrine tumors as targets for therapy.
@ast
Signaling mechanisms in neuroendocrine tumors as targets for therapy.
@en
Signaling mechanisms in neuroendocrine tumors as targets for therapy.
@nl
P2860
P1476
Signaling mechanisms in neuroendocrine tumors as targets for therapy.
@en
P2093
Barbara Zarebczan
Herbert Chen
P2860
P304
P356
10.1016/J.ECL.2010.08.002
P577
2010-12-01T00:00:00Z